BigHat Biosciences

BigHat Biosciences combines machine learning with high-throughput wet lab experiments in a closed-loop system to design safer, more effective antibodies. The company's platform iterates between computational prediction and experimental validation, building proprietary datasets that continuously improve its AI models for antibody optimization.

$148M

Total raised

Closed-loop antibody design platform integrating ML models with high-throughput wet lab experiments. The system generates proprietary datasets that iteratively improve predictions of antibody function, safety, and manufacturability.